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Summary
 Aim To diagnose the etiological factors involved in urinary tract infections (UTI) and to examine anti-
biotic sensitivities in bacteria – causative agents of UTI in female patients with genitourinary ma-
lignancies.
 Materials/Methods Nineteen patients aged between 35 and 75 years treated for genitourinary malignancies and with 
a diagnosis of UTI were examined. The majority of these patients (17) were treated with X rays to 
the pelvic region (tele – and brachytherapy). Six patients were treated for endometrial carcinoma. 
One patient was treated for ovarian cancer, and one for vaginal cancer. Signifi cant bacteriuria was 
defi ned as 104 or more CFUs/ml in quantitative urine examination. Microorganisms were identi-
fi ed according to standard bacteriological methods using bio-Merieux tests. The isolated bacteria 
were tested for antibiotic sensitivity using the ATB Expression system.
 Results E. coli was the most frequently observed causative factor in cases of UTI. E. faecalis strains were the 
next most commonly observed species. One of 11 isolated E. coli strains was resistant to 5 antibi-
otics, a second was resistant to 3 antibiotics and three strains were resistant to 2 antibiotics. E. coli 
strains were classifi ed into 9, and E. faecalis into 4, sensitivity patterns. UTI was diagnosed in four 
patients with stage I B, in four with stage III B and in one patient with stage IV cervical cancer.
 Conclusions E. coli and E. faecalis were the most frequently isolated species from the urine of female patients 
with genitourinary malignancies. These bacteria are among the main causative agents of UTI. The 
results of these investigations may be used for epidemiological purposes: to fi nd the causes and 
sources of nosocomial infections and in the prophylaxis of these infections.
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BACKGROUND
Urinary tract infections (UTI) are very often observed and oc-
cur more frequently in women than in men [1,2]. Infection 
in women is more frequent because of the close proximity of 
the reproductive and lower urinary tracts. Among factors in-
creasing the risk of UTI are diabetes, vaginal infl ammation, 
disorders of the reproductive organs and urinary bladder, 
neoplastic diseases and invasive gynaecological surgery [3,4]. 
Patients with malignant neoplasms of the genitals often suf-
fer simultaneously from infl ammation of the uterus and va-
gina. Patients who have undergone surgery (for cancer or 
for other reasons) may suffer infection of the urinary tract as 
a complication of the surgery, catheterisation or cystoscopy 
[5]. Radiotherapy, which used alongside surgery is a stand-
ard method in the treatment of these tumours, may also be 
a factor increasing the risk of UTI as it causes infl ammatory 
changes to the epithelium of the urinary bladder [6].
General factors in the etiology of UTI are E. coli and other 
organisms of the family Enterobacteriaceae and Enterococcus spp. 
[7–9]. UTI may arise as a nosocomial infection and this is 
the most frequently observed form of this infection [10–12]. 
In epidemiological studies, aimed at fi nding the sources of 
nosocomial infections, it is important to identify the bacte-
rial species involved. One of the methods used to differenti-
ate bacterial species is to determine their sensitivity to drugs. 
Obviously the basic purpose of an antibiogram is to deter-
mine effective antibacterial medication to facilitate effi cient 
treatment of the UTI. Because various species are resistant 
to treatment, for example E. coli which can be resistant to tri-
methoprim-sulfamethoxazole (standard treatment for UTI), 
antibiograms are required to identify other medicines [13]. 
Urinary tract infections (UTI) are among the factors increas-
ing mortality and prolonged stays in hospital [14,15]. One 
symptom of UTI is the occurrence of symptomatic bacteri-
uria in which a count of 104 to 105 CFUs/ml (colony form-
ing units/ml) is the threshold value [5,10,16].
Nonetheless, the majority of papers published on the sub-
ject of urinary tract disorders including infl ammation are on 
patients with cancers of the uterine cervix [17–20] and few 
authors give any special value to UTI as a post therapeutic 
complication after radiotherapy on malignant neoplasms of 
the reproductive system in women [5,6]. Correct etiological 
diagnosis and appropriate treatment can have the effect of 
reducing the numbers of nosocomial infections.
AIM
The purpose of this study was to diagnose the etiological 
factors in urinary tract infection and to determine the drug 
sensitivities of bacteria causing UTI in patients with malig-
nant neoplasms of the reproductive system. A further pur-
pose for the study was to use information gained about drug 
sensitivities of the organisms.
MATERIALS AND METHODS
We investigated 19 patients, aged between 35 and 75 years, 
being treated for malignant neoplasms of the urinary tract 
in the Department of Radiotherapy and Gynaecological 
Oncology at the Great Poland Cancer Centre and diag-
nosed as having symptomatic bacteriuria. The group in-
cluded 17 patients being treated for tumours of the geni-
talia, one patient with cancer of the urethra and one with 
cancer of the urinary bladder. The largest group was pa-
tients treated for cancer of the uterine cervix – 9 patients 
– 5 of whom had undergone previous surgery. Six patients 
suffered from endometrial cancer, 5 of whom underwent 
surgical treatment. One patient was treated for ovarian can-
cer and one for cancer of the vagina.
In the cases of 12 patients this was their fi rst operation. In 
this group of patients, throughout the time of surgery, urine 
was taken from the bladder via urethral catheter. The next 
5 patients were catheterised during radiotherapy. The ma-
jority, 17 patients, were treated with ionising radiation to 
the pelvic region (tele and brachytherapy).
In all cases, clinical fi ndings agreed with histopathological 
fi ndings. The group of women suffering from invasive in-
traepithelial neoplasia of the cervix were in stages I B, III B 
and IV of tumour advancement.
Bacteriuria was defi ned as 104 and higher CFUs/ml of urine 
tested in quantitative tests. Qualitative and quantitative anal-
ysis of urine included CPS, D-Coccosel, Cetrimide, Albicans 
ID2 using quantitative loops. All ‘under bed’ tests were pro-
Test Number Age (years) Results of Urine Culture
1  45 P. mirabilis, S. equisimilis
2  35 E. faecalis, E. coli
3  68 E. coli
4  47 K. pneumoniae
5  70 P. aeruginosa
6  69 E. coli
7  47 E. coli
8  65 E. coli
9  47 E. faecalis, P. aeruginosa
10  67 S. agalactiae
11  68 E. faecalis
12  67 E. coli
13  47 E. coli, E. faecalis
14  54 E. coli
15  70 E. cloacae
16  75 E. coli
17  58 P. mirabilis, P. aeruginosa, K. oxytoca
18  48 E. faecalis, E. coli
19  62 E. coli
Table 1. Etiological factors of UTI in patients with genitourinary 
malignancies.
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duced by the fi rm bio-Merieux. Identifi cation of micro-
organisms was performed according to standard bacteri-
ological methods, also using bio-Merieux tests. Antibiotic 
sensitivity of cultured organisms was assessed using the ATB 
system antibiogram test for ATB Ur and ATB Strep.
RESULTS
The results of urine analysis are shown in Table 1. The most 
frequently isolated organisms were colibacilli. E. coli was cul-
tured from 11 urine samples. The second most commonly 
found species was E. faecalis which was isolated in 5 cases. 
In 13 cases the causative etiological factor in UTI was one 
species of bacteria. In 5 cases, 2 species were involved and 
in one case three species were present.
Tables 2 and 3 show the antibiotic sensitivities of E. coli and E. 
faecalis, the most common causes of UTI. As shown in Table 2, 
E. coli was classifi ed into 7 sensitivity patterns, each representing 
a single strain, and 2 patterns which were displayed by 2 strains. 
One of the 11 strains of E. coli shown in the table, displayed re-
sistance to 5 antibiotics, 1 strain to 3 antibiotics, 3 strains to 2 
antibiotics. All strains were sensitive to norfl oxacin. No strain 
was confi rmed as being resistant to amoxicillin/clarulanic 
acid. Four strains displayed resistance to cefalotin, two to ce-
fotaxime, ciprofl oxacin and cotrimoxazole and one to gen-
tamicin, netylmycin, amikacin and ceftazidime.
Cultures of E. faecalis were classifi ed into 4 sensitivity patterns. 
Three patterns were seen in single strains and one pattern was 
seen in 2 strains (Table 3). As shown in the Table, 2 strains 
were resistant to 4 antibiotics, two strains to 3 antibiotics and 
one strain to 2 antibiotics. All strains had the characteristic 
of resistance to tetracycline and 4 of these were resistant to 
erythromycin. All strains were sensitive to piperacillin, van-
comycin, teikoplanine, ampicillin and penicillin.
P. aeruginosa was isolated from 3 patients and displayed sen-
sitivity to ceftazidine and imipenem. The greatest resistance 
to antibiotics was seen in the case of K. pneumoniae which 
was isolated from one patient, aged 47, who had undergone 
resection of the uterus and left kidney. This organism was 
resistant to amoxicillin/clarulanic acid, cefotaxime, cotri-
moxazole, gentamicin, netylmicin and amikacine. It was 
sensitive only to norfl oxacin.
DISCUSSION
The results of the tests performed show that the most fre-
quent etiological factor causing UTI in female patients with 
Pattern Number Patient Number
Pattern
AMC CFT CTX CAZ AKN GEN NET NOR CIP TSU
1 2,19 2 2 2 2 2 2 2 2 2 2
2 3 2 2 2 2 2 2 2 2 0 0
3 6 1 0 0 2 2 2 2 2 2 2
4 7 2 0 2 2 0 2 2 2 2 2
5 8,12 1 1 2 2 2 2 2 2 2 2
6 13 2 0 0 0 2 2 2 2 2 2
7 14 2 1 2 2 2 2 2 2 2 2
8 16 1 2 2 2 2 2 2 2 2 2
9 18 2 0 2 2 2 0 0 2 0 0
Table 2. Sensitivity Patterns of E. coli.
2 – Sensitive; 1 – Mildly Sensitive; 0 – Resistant.
AMC – amoxicillin/clarulanic acid; GEN – gentamicin; CFT – cefalotine; NET – netylmicin; CTX – Cefotaxime; NOR – Norfl oxacin; CAZ – Ceftazidime; 
CIP – Ciprofl oxacin; AKN – Amikacin; TSU – Cotrimoxazole.
Pattern Number Patient Number
Pattern
PIC TET ERY CIP VAN TEC GEN KAN AMP PE
1 2,9 2 0 0 0 2 2 0 2 2 2
2 11 2 0 0 0 2 2 1 2 2 2
3 13 2 0 0 0 2 2 2 2 2 2
4 18 2 0 1 2 2 2 0 2 2 2
Table 3. Sensitivity patterns of E. faecalis.
2 – Sensitive; 1 – Mildly Sensitive; 0 – Resistant.
PIC – Piperacillin; TEC – Teikoplanin; TET – Tetracycline; GEN – Gentamicin; ERY – Erythromycin; KAN – Kanamicin; CIP – Ciprofl oxacin; 
AMP – Ampicillin; VAN – Vancomycin; PE – Penicillin.
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neoplastic diseases of the sex organs was E. coli. This agrees 
with other authors in that E. coli is the most commonly ob-
served bacterial species causing UTI [8]. Four strains of E. 
coli displayed resistance to cephalosporins, frequently used 
drugs in the treatment of UTI. Other authors have also de-
scribed an increase in the number of species resistant to ce-
phalosporins in cases of UTI [21]. Our results draw atten-
tion to the emergence of organisms resistant to ciprofl oxacin 
and cotrimoxazole, drugs many authors list as standard treat-
ments for UTI [22–24]. Also, antibiograms on tested ma-
terials showed that 3 strains of E. faecalis were resistant to 
aminoglycosides, antibiotics used in the treatment of UTI 
[25]. VRE (Vancomycin Resistant Enterococcus) were not 
observed though these are currently a serious threat owing 
to high drug resistance in these species. Attention is drawn 
to the emergence of a strain of K. pneumoniae, which is mul-
ti-drug resistant, isolated from a patient being treated for 
cancer of the uterine cervix. Other authors have also written 
about the high resistance of K. pneumoniae [26,27].
The results of our investigation show UTI in four patients 
with stage I B, four with stage III B and one with stage IV 
cancer of the uterine cervix. Prasad et al. (1995) showed that 
advanced cervical cancer may have effects leading to UTI. 
Authors have described a higher percentage (33.3%) of in-
fections in patients with stage III cervical cancer in compar-
ison to patients with stage II disease (16.7% UTI) [6].
CONCLUSION
The results of this study show that E. coli and E. faecalis may 
generally be isolated from the urine of female patients with 
neoplastic disease of the genitourinary tract and that these 
species are therefore the most common causative factor in in-
fection of the urinary tract. Comparison of species’ resistance 
patterns may be used in epidemiological studies in order to 
discover the source of infections and therefore has a profound 
signifi cance in the prophylaxis of nosocomial infections.
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